TNXP (MC $32 M) (Cash $34 M) O/S 7.5 M / Phase 3 Data in 1H 2018 =10+ Bagger Potential !!

Another terrible undervalued stock for you guys which trading below Cash and which is close to phase 3 readout if successfull the drug will have around $600+ Million in Sales Potential . The Company has only 7.5 Million Shares outstanding and Baker bros who are really one of the most successful investors in the Biotech Sector is second largest shareholder . TNXP should be valued right now around $15 per share for their Phase 3 program and huge cash balance and if phase 3 outcome is positive then sky is the limit .GL